Search Results - "Afacan, Berna"

Biological variation estimates of prothrombin time, activated partial thromboplastin time, and fibrinogen in 28 healthy individuals by Falay, Mesude, Senes, Mehmet, Korkmaz, Selcuk, Turhan, Turan, Okay, Murat, Öztürk, Berna Afacan, Yücel, Doğan, Ozet, Gulsum

“…Background Although tests of global hemostasis prothrombin time (PT) and activated partial thromboplastin time (aPTT) should not be used for prediction of…”
Get full text

Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect by Tığlıoğlu, Mesut, Tığlıoğlu, Pınar, Yıldız, Abdulkerim, Reis Aras, Merih, Sağlam, Buğra, Afacan Öztürk, Hacer Berna, Adabağ, Ayşegül, Albayrak, Murat

“…What is known and objective Primary myelofibrosis (PMF) is characterized by myeloid cell proliferation and prominent bone marrow fibrosis. Ruxolitinib, a…”
Get full text

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma by Falay, Mesude, Afacan Öztürk, Berna, Güneş, Kürşad, Kalpakçı, Yasin, Dağdaş, Simten, Ceran, Funda, Özet, Gülsüm

“…Atypical chronic lymphocytic leukemia (CLL) is most frequently confused with mantle cell lymphoma (MCL). Several markers may contribute to the diagnosis of…”
Get full text

Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors by Yıldız, Abdulkerim, Albayrak, Murat, Pala, Çiğdem, Şahin, Osman, Afacan Öztürk, Hacer Berna, Güneş, Gürsel, Maral, Senem, Okutan, Harika

“…Bacterial infections and febrile neutropenia (FN) are major causes of morbidity and mortality in patients with hematological malignancy. The aim of this study…”
Get full text

Anorectal Pathologies in the Course of Acute Leukaemias; Predictive Parameters by Yilmaz, Fatma, Saglam, Bugra, Gorduk, Ufuk, Kalan, Ugur, Ozturk, Hacer Berna Afacan, Gunes, Ahmet Kursad, Albayrak, Murat

“…Patients with leukaemia are exposed to infections as long as they are neutropenic. During this period, anorectal pathologies are among the common foci of…”
Get full text

Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia by Yildiz, Abdulkerim, Albayrak, Murat, Pala, Cigdem, Sahin, Osman, Kus, Arif, Maral, Senem, Comert, Pinar, Ozturk, Hacer Berna Afacan

“…Aims: Splenectomy is still the standard salvage therapy in immune thrombocytopenia (ITP) cases refractory to corticosteroid therapy. The aim of this study was…”
Get full text

The outcome of COVID-19 in patients with hematological malignancy by Tığlıoğlu, Pınar, Albayrak, Murat, Tığlıoğlu, Mesut, Öztürk, Hacer Berna Afacan, Aras, Merih Reis, Sağlam, Buğra, Maral, Senem

“…Summary Objective The aim of this study was to examine the effect of coronavirus disease 2019 (COVID-19) on the malignancy-related clinical course and overall…”
Get full text

Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients by Akyol, Pinar, Yildiz, Abdulkerim, Albayrak, Murat, Ozturk, Hacer Berna Afacan, Maral, Senem, Aras, Merih Reis, Yilmaz, Fatma, Saglam, Bugra, Tiglioglu, Mesut, Malkan, Umit Yavuz

“…Aims: Primary myelofibrosis (PMF) and post-polycythemia vera (PV) or essential thrombocythemia (ET) myelofibrosis (MF) have many common features in terms of…”
Get full text

Effect of Gibberellic Acid on the Levels of Tumor Necrosis Factor-α, Interleukin-4 and Interleukin-10 in Rats by AFACAN ÖZTÜRK, Hacer Berna, ERİN, Nuray, BALCI, Mustafa Kemal

“…Objective: Gibberellic acid is a plant growth factor. Several studies have demonstrated the effect of gibberellic acid on tumor development. Tumor necrosis…”
Get full text

Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience by Tığlıoğlu, Pınar, Albayrak, Murat, Yıldız, Abdulkerim, Tığlıoğlu, Mesut, Sağlam, Buğra, Aras, Merih Reis, Yılmaz, Fatma, Maral, Senem, Öztürk, Hacer Berna Afacan, Malkan, Ümit Yavuz

“…In some patients with chronic myeloproliferative neoplasms, myelofibrosis (MF) develops as natural evolution of the disease. The aim of this study was to…”
Get full text

Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma by Cömert, Pınar, Yıldız, Abdulkerim, Yıldırım, Murat, Afacan Öztürk, Hacer Berna, Pala, Çiğdem, Albayrak, Murat, Aylı, Meltem

“…Low-grade Nonhodgkin lymphoma (LG-NHL) is characterized by indolent clinical course, which consist of marginal zone lymphoma (MZL), follicular lymphoma (FL),…”
Get full text

IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION by Senem Maral, Murat Albayrak, Berna Afacan Öztürk, Ünsal Han, Merih Reis Aras, Gülten Korkmaz, Simten Dagdas, Aynur Albayrak, Gülsüm Özet

“…Objective: Autologous hematopoetic stem cell transplantation (aHSCT) after high dose chemotherapy is a standard treatment for multiple myeloma (MM) patients…”
Get full text

A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment by Afacan Öztürk, Hacer Berna, Albayrak, Murat, Pala Öztürk, Çiğdem, Yıldız, Abdulkerim, Maral, Senem, Önder, Evrim

“…Sarcoidosis is known to be associated with higher incidence of solid tumors and hematological malignancies. ALK(−) CD30(+) anaplastic large cell lymphoma is a…”
Get full text

THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE by Merih Reis Aras, Murat Albayrak, Hacer Berna Afacan Ozturk, Fatma Yilmaz, Bugra Saglam, Mehlika Panpalli Ates, Selim Selcuk Comoglu, Abdulkerim Yildiz

“…Objective: Therapeutic plasma exchange (TPE), is based on the removal of pathogenic substrates from plasma with replacement fluid. TPE is being used in the…”
Get full text

INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT by Merih Reis Aras, Senem Maral, Hacer Berna Afacan Ozturk, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Murat Albayrak, Mustafa Onder

“…Case report: Inappropriate ADH syndrome is a cause of hyponatremia with increased ADH secretion despite normal plasma osmolality and euvolemic state.There are…”
Get full text

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT by Merih Reis Aras, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Senem Maral, Hacer Berna Afacan Ozturk, Murat Albayrak, Neslihan Olgun

“…Case report: Ionizing radiation and chemotherapeutic agents can cause carcinogenic effects by causing DNA damage.A 40-year-old female patient diagnosed with…”
Get full text

Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge by Yıldız, Abdulkerim, Şahin, Osman, Öztürk, Çiğdem Pala, Öztürk, Hacer Berna Afacan, Maral, Senem, Albayrak, Murat

“…Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare and aggressive malignancy of natural killer (NK) cells. It is now regarded as a distinct…”
Get full text

Novel mutated Dubin–Johnson syndrome diagnosed during acute promyelocytic leukemia treatment by Afacan Öztürk, Hacer Berna, Albayrak, Murat, Reis Aras, Merih, Yılmaz, Fatma, Düzkale, Neslihan

Get full text

Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study by Sayin, Selim, Kiliacslan, Emrah, Yildirim, Murat, Ozturk, Hacer Berna Afacan, Yilmaz, Esra Safak, Albayrak, Murat, Kaptan, M. Kursat, Ayli, Meltem

Get full text

Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia by Maral, Senem, Albayrak, Murat, Dagdas, Simten, Yıldız, Abdulkerim, Yıldırım, Rahsan, Oz, Merih, Pala, Cigdem, Afacan Ozturk, Hacer Berna, Bay, Ilker, Ozet, Gulsum, Dilek, Imdat

“…Hairy cell leukemia is a rare B-cell lymphoproliferative disorder. It has an indolent course with relapse and remission periods. The aim of this study was to…”
Get full text